Anti-Human CD20 Recombinant Antibody(Ocrelizumab)

Name: Anti-Human CD20 Recombinant Antibody(Ocrelizumab)
Brand: KMD Bioscience
SKU: YR1145

YR1145

科研级 Ocrelizumab ( 奥瑞组单抗 ), Anti-CD20 Recombinant Antibody, Research Grade Ocrelizumab

DATASHEET MSDS

Product Description

Alias	科研级 Ocrelizumab ( 奥瑞组单抗 ), Anti-CD20 Recombinant Antibody, Research Grade Ocrelizumab
Catalog Number	YR1145
Molecular Name	Ocrelizumab
Size	1mg, 5mg
Clonity	Monoclonal
Purity	>95% as determined by SDS-PAGE
Concentration	1mg/ml
Antibody Isotype	IgG1
Formulation	PBS, pH7.5
Background	Ocrelizumab, sold under the brand name Ocrevus, is a pharmaceutical drug for the treatment of multiple sclerosis (MS). It is a humanized anti-CD20 monoclonal antibody. It targets CD20 marker on B lymphocytes and hence is an immunosuppressive drug.
CAS Number	637334-45-3
Application	ELISA, IP, FCM, FuncS, Neut, IF
Storage Condition	It is recommended to aliquote and store at -20°C for long term storage. Avoid repeated freezing and thawing cycles.
Remarks	This product is for research use only.
Shipping Condition	Shipped on ice packs.
Molecular Weight	145 kDa
Target	CD20[Homo sapiens]

Login